One Treatment for High Blood Pressure and Cholesterol Could Help Patients with Metabolic Syndrome

Recent research has shown that babies born today are fatter than babies born twenty years ago, but scientists at Harvard Medical School and Massachusetts General Hospital have identified a molecular switch that regulates fat and cholesterol production. They hope this will lead to a treatment for metabolic syndrome.

Metabolic syndrome is a condition where patients have high cholesterol, obesity, type-2 or pre-diabetes and high blood pressure. This usually affects adults. The study’s lead investigator, Dr. Ander Näär said “We have identified a key protein that acts together with a family of molecular switches to turn on cholesterol and fat (or lipid) production. The identification of this protein interaction and the nature of the molecular interface may one day allow us to pursue a more comprehensive approach to the treatment of metabolic syndrome.” Näär is assistant professor of cell biology at Harvard Medical School and the Massachusetts General Hospital Cancer Center.

Ultrasound Affects Brain In Some Developing Mammals – Excessive Use Retards Development in Babies

Researchers believe that prolonged and frequent use of ultrasound on some pregnant mammals may cause abnormalities in the developing brain. So far, the research has only been done on mice. Further research is needed to determine if there are any negative effects on humans.

The Yale researchers injected more than 335 fetal mice at embryonic day 16 with special markers to track neuronal development. They found that when the mice were exposed to ultrasound waves (USW) for 30 minutes or longer, it caused a small but statistically significant number of neurons to remain scattered within inappropriate cortical layers and/or in the adjacent white matter.

Lung Cancer Gene Test Predicts Who Needs Chemotherapy – Tumor Profiles Determines High Risk Patients

Scientists at Duke University have developed a genomic test to determine which patients with early-stage lung cancer need chemotherapy and which do not. They describe the chemotherapy as a “toxic regimen of drugs”.

The test could potentially save thousands of lives each year by allowing doctors to make the important recommendation for chemotherapy. The developers of the test, at Dukes Institute for Genome Sciences & Policy, say that some patients should receive it, but are currently advised against it.

Treating Cholesterol Reduces Risk of Second Stroke – Lipitor Lowered Risk 16 Percent


If patients aggressively reduce their cholesterol levels they can reduce their risk of stroke by up to 16 percent, according to an international team of researchers. This is important because 40 percent of patients who experience a stroke will experience a second stroke within the next five years.

The study included 4,731 patients who experienced a stroke or TIA (mini stroke) within 6 months of enrollment. None of the patients had a history of heart disease. All of the patients had a mildly elevated cholesterol level. They were given either an 80 mg of Lipitor® or a placebo. They were then monitored for an average of five years.

Syndicate content


Post to Facebook

Important: The material on Best Syndication is for informational purposes only and is not meant to be advice. Authors may have or will receive monetary compensation from the company's product/s mentioned. You should always seek professional advice before making any legal, financial or medical decisions and this website cannot substitute or replace any trained professional consultation.
Use of this site means that you agree to our TERMS OF SERVICE

Advertise On This Site
Copyright © 2006-2015 By Best Syndication All Rights Reserved